ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME

Title:

ORAL SOLID FORMULATION CONTAINING IRINOTECAN AND METHOD OF PREPARING THE SAME

Document Type and Number:

WIPO Patent Application WO/2017/003120

Kind Code:

A1

Abstract:

An oral solid formulation includes irinotecan or a pharmaceutically acceptable salt thereof as an active ingredient, and an acidifying agent.

More Like This:

JP2019031474	ANTICANCER DRINKABLE PREPARATIONS
JP2021527675	Platinum-based amphipathic prodrug
JP4452403	Effervescent preparation

Inventors:

PARK CALEB HYUNG MIN (KR)
JUNG MYEONG KI (KR)
KIM JIN CHEUL (KR)
KIM YONG IL (KR)
PARK JAE HYUN (KR)
WOO JONG SOO (KR)

Application Number:

PCT/KR2016/006513

Publication Date:

January 05, 2017

Filing Date:

June 20, 2016

Export Citation:

Assignee:

HANMI PHARM IND CO LTD (KR)

International Classes:

A61K47/12; A61K9/16; A61K9/20; A61K9/48; A61K31/4745

Domestic Patent References:

Foreign References:

Other References: